[HTML][HTML] The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer
ST Reis, LS Timoszczuk, J Pontes-Junior, N Viana… - Clinics, 2013 - SciELO Brasil
OBJECTIVE: The aim of this study is to verify the expression of proteins that are controlled by
miR-let7c, 100 and 218 using immunohistochemistry in tissue microarray representative of …
miR-let7c, 100 and 218 using immunohistochemistry in tissue microarray representative of …
Importance of miR-20a expression in prostate cancer tissue
M Pesta, J Klecka, V Kulda, O Topolcan… - Anticancer …, 2010 - ar.iiarjournals.org
Background: MicroRNAs (miRNAs), which are endogenously expressed regulatory
noncoding RNAs, have an altered expression in tumor tissues. MiRNAs regulate cancer …
noncoding RNAs, have an altered expression in tumor tissues. MiRNAs regulate cancer …
Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis
Objective: MicroRNAs (miRNAs) are small noncoding regulatory RNAs (19–25 nucleotides)
that play a major role in regulation of gene expression. They are responsible for the control …
that play a major role in regulation of gene expression. They are responsible for the control …
[HTML][HTML] MicroRNA 100: a context dependent miRNA in prostate cancer
OBJECTIVE: MicroRNAs are noncoding RNA molecules involved in the development and
progression of tumors. We have found that miRNA-100 is underexpressed in metastatic …
progression of tumors. We have found that miRNA-100 is underexpressed in metastatic …
[HTML][HTML] MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth
N Nadiminty, R Tummala, W Lou, Y Zhu, XB Shi… - PloS one, 2012 - journals.plos.org
Purpose Prostate cancer (PCa) is characterized by deregulated expression of several tumor
suppressor or oncogenic miRNAs. The objective of this study was the identification and …
suppressor or oncogenic miRNAs. The objective of this study was the identification and …
[HTML][HTML] Low expression of microRNA‑30c promotes prostate cancer cells invasion involved in downregulation of KRAS protein
J Zhang, X Wang, Y Wang, R Peng… - Oncology …, 2017 - spandidos-publications.com
Aberrant microRNA expression is associated with tumor development. The present study
aimed to elucidate the role of miR‑30c in the development of prostate cancer. Quantitative …
aimed to elucidate the role of miR‑30c in the development of prostate cancer. Quantitative …
[HTML][HTML] MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer
M Kato, Y Goto, R Matsushita… - International …, 2015 - spandidos-publications.com
Our past studies of microRNA (miRNA) expression signatures of cancers including prostate
cancer (PCa) revealed that microRNA-26a and microRNA-26b (miR-26a and miR-26b) were …
cancer (PCa) revealed that microRNA-26a and microRNA-26b (miR-26a and miR-26b) were …
microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer
Prostate cancer is the most common cancer among men in the western world. Clinical
practice is continuously challenged by the pitfalls of the available diagnostic tools …
practice is continuously challenged by the pitfalls of the available diagnostic tools …
[HTML][HTML] The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer
Y Goto, S Kojima, R Nishikawa, H Enokida… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Our recent study of microRNA (miRNA) expression signatures in prostate cancer (PCa) has
revealed that all members of the miR-23b/27b/24-1 cluster are significantly downregulated …
revealed that all members of the miR-23b/27b/24-1 cluster are significantly downregulated …
MicroRNA profile analysis of human prostate cancers
AW Tong, P Fulgham, C Jay, P Chen, I Khalil… - Cancer gene …, 2009 - nature.com
We examined the microRNA (miRNA) expression profile of 40 prostatectomy specimens
from stage T2a/b, early relapse and non-relapse cancer patients, to better understand the …
from stage T2a/b, early relapse and non-relapse cancer patients, to better understand the …